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It has long been known that the electrophysiological effects of many cardioactive drugs strongly depend
on the rate dependent frequency. This was recognized first for class I antiarrhythmic agents: their Vmax
suppressive effect was attenuated at long cycle lengths. Later many Ca2þ channel blockers were also
found to follow such kinetics. The explanation was provided by the modulated and the guarded receptor
theories. Regarding the duration of cardiac action potentials (APD) an opposite frequency-dependence
was observed, i.e. the drug-induced changes in APD were proportional with the cycle length of stimu-
lation, therefore it was referred as “reverse rate-dependency”. The beat-to-beat, or short term variability
of APD (SV) has been recognized as an important proarrhythmic mechanism, its magnitude can be used
as an arrhythmia predictor. SV is modulated by several cardioactive agents, however, these drugs modify
also APD itself. In order to clear the drug-specific effects on SV from the concomitant unspecific APD-
change related ones, the term of “relative variability” was introduced. Relative variability is increased
by ion channel blockers that decrease the negative feedback control of APD (i.e. blockers of ICa, IKr and IKs)
and also by elevation of cytosolic Ca2þ. Cardiac arrhythmias are also often categorized according to the
characteristic heart rate (tachy- and bradyarrhythmias). Tachycardia is proarrhythmic primarily due to
the concomitant Ca2þ overload causing delayed afterdepolarizations. Early afterdepolarizations (EADs)
are complications of the bradycardic heart. What is common in the reverse rate-dependent nature of
drug action on APD, increased SV and EAD incidence associated with bradycardia.
© 2019 Elsevier Ltd. All rights reserved.Contents
1. Rate-dependent nature of antiarrhythmic drug action . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2. Reverse rate-dependent action of drugs on action potential duration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
3. Electrical restitution and electrical alternans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
4. Beat-to-beat variability of action potential duration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
5. Frequency-dependent properties of cardiac arrhythmias . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
6. Concluding remarks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
Funding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
Declaration of competing interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00gy and Pharmacotherapy, University of Szeged, Szeged, Hungary.
. Varro).
work. Both are to be considered first authors.
Implication of frequency-dependent protocols in antiarrhythmic and proarrhythmic drug testing,
y, https://doi.org/10.1016/j.pbiomolbio.2019.11.001
P.P. Nanasi et al. / Progress in Biophysics and Molecular Biology xxx (xxxx) xxx2Supplementary data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 001. Rate-dependent nature of antiarrhythmic drug action
Ignorance of the rate-dependent nature of cardioactive drug
actions was the reason for many malpractice cases when class 1/C
antiarrhythmics were applied in acute cardiac infarct patients. As
we know from the CAST Study application of 1/C drugs, like fle-
cainide or encainide, increased the mortality comparing to patients
not treated with these agents (Echt et al., 1991). It turned out that 1/
C antiarrhythmics (Naþ-channel inhibitors particularly) have very
slow offset kinetics resulting in the blockade of normally coupled
action potentials too in addition to suppression of early prematures.
Subclassification of class I antiarrhythmics is usually done by their
offset kinetics; in other words, by the time constant of recovery
from reduction in upstroke velocity (Vmax) block caused by the
agent following high frequency stimulation (Campbell, 1983). Using
this approach 1/B drugs (mexiletine, lidocaine and tocainide) were
characterized with the fastest offset kinetics ranging within a few
hundreds of milliseconds. 1/A compounds have somewhat slower
offset kinetics: in the range of a few seconds, while in the case of 1/
C drugs the time course of offset is extended to more than 10 s. In
accordance with this behaviour, the frequency-dependence of
various class I antiarrhythmics are different under steady-state
conditions as well, since drugs having fast offset kinetics are
more active at rapid heart rates and can selectively block premature
extra action potentials without suppressing the propagation of
normal action potentials (antiarrhythmic effect). In contrast, drugs
with slow kinetics cause a marked steady-state block at normal
heart rates increasing the risk of re-entry arrhythmias due to
development of conduction block (Campbell, 1992).
The rate-dependent nature of the effects of class I antiarrhyth-
mics is based on their rate-dependent interaction with fast Naþ
channels which are responsible for the rapid action potential up-
stroke, determining this way the intraventricular conduction ve-
locity. At a molecular level the modulated receptor hypothesis
provides an explanation for the rate-dependent drug action
(Hondeghem and Katzung, 1984). The central point of this theory is
the assumption that the various channel states (resting, open and
inactivated) have different affinity to bind the antiarrhythmic drug
and the drug-binding channel state in not conductive (Hille, 1977).
Consequently, at higher rate dependent frequency the relative
contribution of the open and inactivated channel population in-
creases in line with the stronger rate-dependent (also called use-
dependent) inhibition. An alternative explanation for the rate-
dependent blockade is provided by the guarded receptor theory
(Grant et al., 1984; Starmer and Grant, 1985). This argumentation is
based on the assumption that a charged (or hydrophilic) antiar-
rhythmic compound can access and leave its binding site through
the hydrophilic conducting pore, which is guarded by the closed
gates (Starmer et al., 1984). Consequently, both association and
dissociation of drug to/from its binding site is possible only when
the channel is in open state. Bothmodels are in accordancewith the
voltage-dependent nature of Naþ channel blockade demonstrated
under voltage clamp conditions and allow differentiation between
open channel block in the case of quinidine, and inactivated
channel block in the case of lidocaine (Hondeghem and Katzung,
1977; Colatsky, 1982; Hondeghem and Matsubara, 1988). The
guarded receptor theory predicts that channels equipped with
inactivation gates can be inhibited in a rate-dependent mannerPlease cite this article as: Nanasi, P.P et al., Implication of frequency-dep
Progress in Biophysics and Molecular Biology, https://doi.org/10.1016/j.pbprovided that the blocker molecule is charged. Indeed, various
blockers of the L-type cardiac Ca2þ channels (class IV antiarrhyth-
mics, including verapamil derivatives and dihydropyridines) were
also reported to show the phenomenon of rate-dependent inhibi-
tion (Hondeghem and Katzung, 1984). Accordingly, it appears that
the rate-dependent nature of the channel-drug interaction may be
a general property of drugs acting on cardiac ion channels.2. Reverse rate-dependent action of drugs on action potential
duration
It has to mentioned that physiologically at fast heart rate APD is
short and as heart rate slows down, APD lengthens producing an
exponential like curve called recently dynamic restitution curve
(Osadchii, 2017).
In sharp contrast with the use-dependent Naþ channel blockade
and Vmax suppression caused by class I antiarrhythmics, the repo-
larization lengthening effect of class III drugs (including Kþ-channel
inhibitors particularly) increases with the increase of the pacing
cycle length, ie. by slowing of the heart rate. Since class III antiar-
rhythmics act by increasing the refractory period due to prolon-
gation of action potential duration (APD) this means that the APD
lengthening effect of these agents is augmented at lower fre-
quencies. This “reverse rate-dependent” behavior was initially
observed with blockers of the rapid delayed rectifier Kþ current
(Jurkiewicz and Sanguinetti, 1993), however, it was observed with
many other agents that cause lengthening of APD. Unfortunately,
the reverse rate-dependency is therapeutically unfavourable
because the beneficial drug effect is relatively small at shorter cycle
lengths, while the incidence of early afterdepolarizations is
increased at normal or longer cycle lengths, which effect is known
to be proarrhythmic (Hondeghem and Snyders, 1990; Nair and
Grant, 1997; Weirich and Antoni, 1998). This may explain the
disappointing results obtained with selective IKr inhibitor d-sotalol,
which increased the mortality of myocardial infarct patients in the
SWORD Study (Waldo et al., 1995). Recently a strong reverse rate
dependent effect of IKr current blockers was also observed in hu-
man induced pluripotent stem cell-derived cardiomyocytes (hiPSC-
CMs) (Lemoine et al., 2018).
Several hypotheses were developed so far to explain the
mechanism of the reverse rate-dependence, including the accu-
mulation of IKs due to incomplete channel deactivation at short
cycle length (Jurkiewicz and Sanguinetti, 1993), the accumulation
of Kþ ions in the extracellular clefts (Yang and Roden, 1996),
frequency-dependent changes in action potential configuration
(Rocchetti et al., 2001; Virag et al., 2009), and the modulated re-
ceptor theory with the hypothesized reduction of drug binding to
open channel state. These explanations were able to partially
explain the reverse rate-dependent property of IKr blockers, how-
ever, failed to provide convincing explanation for the general
feature of reverse rate-dependency.
Zaza suggested first that reverse rate dependency is a general
largely species independent phenomenon as a consequence of non-
linearity of the dV/dt versus APD relationship (Zaza and Varro,
2006; Zaza, 2010). As demonstrated in Fig. 1.A,B, drugs known to
either lengthen or shorten APD develop more pronounced effects
on APD at longer than at shorter cycle length (Banyasz et al., 2009;
Zaza, 2010). It has also been shown that the phenomenon is really aendent protocols in antiarrhythmic and proarrhythmic drug testing,
iomolbio.2019.11.001
Fig. 1. A,B: Reverse rate-dependent changes of APD evoked in canine ventricular tissues by superfusion of a variety of drugs. C: Relationship between APD and net membrane
current obtained from the pharmacological experiments. Membrane current was calculated from the slope of the plateau at half-duration of APD. D-E: Changes in action potential
duration induced with inward and outward current pulses. F: Current-APD relationship obtained from the experiments using current injections.
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including canine, guinea pig and human cardiac preparations
(Barandi et al., 2010a). Finally, experiments performed in rabbits
and rats revealed the critical point, since APD changes biphasically
with cycle length in rabbit, while in rat there is a relatively flat APD
or QTc versus CL relation (Mulla et al., 2018) or an inverse rela-
tionship between APD and the stimulation cycle length (Nanasi
et al, 1996). Drug actions on APD in both rabbits and rats were
proportional with APD rather than with the pacing cycle length
(Barandi et al., 2010a, 2010b). These results clearly indicate that the
action of any drug on APD is stronger when the APD is long (usually
at longer cycle lengths in larger mammals) because the net mem-
brane current flowing during the plateau phase of the action po-
tential is smaller under these conditions. Consequently, any given
change in the plateau current (evoked by a drug action) is expected
to cause a relatively larger shift in APD as demonstrated in Fig. 1.C.
Strong support of this theory is provided by the data presented in
Fig. 1.D-F, where drug actions were mimicked by using inward and
outward current pulses in order to lengthen and shorten APD,
respectively. Although the shapes of the curves are not fully iden-
tical for drug and current applications, the reverse rate-dependent
character of the changes is evident in both cases. In summary, the
inverse relationship between APD and net plateau current may be
mainly responsible for the reverse rate-dependency (Fig. 1.C and
1.F).
3. Electrical restitution and electrical alternans
To critically study both antiarrhythmic and proarrhythmic
properties of a certain drug the electrical restitution properties of
cardiac tissues should be also considered. The standard (distin-
guishable from dynamic) electrical restitution curves can be
defined by the relation of the APD lengthening of extra beats (S2) by
gradually increasing the coupling or diastolic intervals from aPlease cite this article as: Nanasi, P.P et al., Implication of frequency-dep
Progress in Biophysics and Molecular Biology, https://doi.org/10.1016/j.pbconstant basic cycle length (S1eS1). As seen in Fig. 2A APD is
gradually increased (steepened APD restitution) as diastolic inter-
val increases. This phenomenon and its role in arrhythmogenesis
including its pharmacological modulation (Varro et al., 1985;
Garfinkel et al., 2000;Wu et al., 2002) had been described long time
ago (Boyett and Jewell,1978; Elharrar and Surawicz,1983; Robinson
et al., 1987; Nash et al., 2006; Pak et al., 2004), but its significance in
arrhythmogenesis gained also particular attention in the last
decade (Osadchii, 2017; Shattock et al., 2017).
According to the APD restitution hypothesis, by gradual increase
of the diastolic or coupling intervals due to the propagation of an
extra beat, the next possible extra beat would encounter longer
APD and ERP and as a consequence, local conduction block or wave
break can occur. If the electrical restitution curve is steeper, it
would favour such an effect and impediment of local impulse
propagation ie. conduction blockmay occur. This is considered to be
proarrhythmic (Garfinkel et al., 2000; Osadchii, 2017). In the con-
trary flattened restitution curve should have an opposite conse-
quence. Regional difference in the electrical restitution curves
(Morgan et al., 1992; Riccio et al., 1999; Boukens et al., 2017) can
also favour arrhythmogenesis (Osadchii, 2017). As Fig. 2B shows
restitution properties are markedly different in physiological con-
dition between ventricular and Purkinje fibres, therefore this
aspect, and its influence on arrhythmogenesis and possible anti-
arrhythmic actions should be studied more intensively in the
future.
It had been reported that certain antiarrhythmic drugs
decreased the slope of APD restitution (flattened APD restitution) in
both cardiac Purkinje (Varro et al, 1985) and ventricular (Garfinkel
et al., 2000) muscle (Fig. 3). APD alternans (Fig. 3) also relates to
electrical restitution in the sense that steeper restitution curve fa-
cilitates its appearance (Weiss et al, 2011, 2015). When fast sudden
changes in constant frequency (dynamic restitution) happen, its
first beat interval can result shorter APD due to short coupling orendent protocols in antiarrhythmic and proarrhythmic drug testing,
iomolbio.2019.11.001
Fig. 2. Electrical APD restitution curves from ventricular (square) and Purkinje (circles) fibres measured by the dynamic (A) and standard (B) protocols in undiseased human donor
heart by applying the standard microelectrode technique. In (A), S1eS1 was gradually increased after trains of 25 beats, in (B) S1eS2 was gradually increased after every train of 25
beats from basic cycle length (S1eS1) of 1000ms (unpublished results from Department of Pharmacology and Pharmacotherapy, University of Szeged).
Fig. 3. Flattening the slope of electrical restitution by Class I antiarrhythmic mexiletine and flecainide in dog Purkinje fibres (A, from Varro et al., 1985), with permission) and rabbit
ventricular muscle (B, from Garfinkel et al., 2000, with permission).
APDt¼ action potential durations of extrasystoles with increasing D1 (test)
APDb¼ action potential durations of basic cycle length.
P.P. Nanasi et al. / Progress in Biophysics and Molecular Biology xxx (xxxx) xxx4diastolic interval, which would consequently results longer
coupling or diastolic interval for the next beat, resulting longer APD
and if this continues a short-long-short-long APD pattern, called
action potential alternans would develop. It is possible that each
action potential is simultaneously shortened or prolonged in all
sites (concordant alternans, Fig. 4A). However, further increase of
stimulation frequency so called discordant APD alternans (Fig. 4B)Please cite this article as: Nanasi, P.P et al., Implication of frequency-dep
Progress in Biophysics and Molecular Biology, https://doi.org/10.1016/j.pbcan be developed when APDs at further distance or regions can
alternate with opposite phases markedly increasing dispersion of
repolarization and consequently enhancing substrate for arrhyth-
mias (Pastore et al., 1999). Therefore, applying the dynamic resti-
tution protocols ie. gradually decreasing steady state pacing cycle
lengths until ERP is achieved can be a useful protocol to detect both
proarrhythmic and antiarrhythmic drug actions.endent protocols in antiarrhythmic and proarrhythmic drug testing,
iomolbio.2019.11.001
Fig. 4. Electrical concordant (A) and discordant (B) alternans. Detailed explanation in
the text at paragraph entitled “Electrical restitution and electrical alternans”.
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changes regardless of the fact whether the dynamic or standard
restitution protocols are used -including electrical alternans-can be
attributed to the not fully recovery from inactivation and deacti-
vation of different inward currents such INa and ICa or outward
currents such as Ito, IKr, IKs and ICl depending on the gating prop-
erties of these channels (Ni et al., 2018; Tolkacheva et al., 2006).
Also intracellular ion concentration changes for Ca2þ and Naþ can
activate electrogenic Naþ-Ca2þ exchanger (NCX) and Naþ/Kþ pump
with different time course as frequency changes result noticeable
alterations in the extracellular Kþ-concentration in the clefts
resulting changes both in depolarizing and repolarizing ionic
currents.
Electrical alternans can also arise from frequency dependent
properties of Ca2þ-handling. At fast pacing amplitude of the
intracellular Ca2þ-transient can start alternating which than con-
verts into repolarization alternans due to the function of NCX and
other possible Ca2þ-sensitive currents. Coupling between Ca2þ and
repolarization alternans can be intrinsically bidirectional, but some
studies suggest that Ca2þ alternans is the primarily course (Díaz
et al., 2004; Pruvot et al., 2004). The mechanism underlying Ca2þ
alternans can be attributed to the combination of steep SR load
release relationship and insufficient SR refilling time.
4. Beat-to-beat variability of action potential duration
Incidence of cardiac arrhythmias depend on the simultaneous
presence of a substrate and a trigger. In light of this it is not sur-
prising that arrhythmia propensity is also rate-dependent, since
both the duration of the refractory period, which is strongly
dependent on APD, as well as the chance of development of elec-
trical inhomogeneity are rate-dependent. A prominent component
of temporal inhomogeneity is the beat-to-beat variability of APD,
called also as short termvariability (SV). The phenomenon has been
studied in a variety of cardiac preparations including the human
heart (Zaniboni et al., 2000; Hinterseer et al., 2008, 2009; Abi-
Gerges et al., 2010; Sur et al., 2013), and it was found that eleva-
tion of SV is definitely proarrhythmic. Furthermore, SV is consid-
ered as one of the best arrhythmia predictors (Thomsen et al., 2004,
2006; Tereshchenko et al., 2010; Hinterseer et al., 2010; Jacobson
et al., 2011). Several factors are involved in the modulation of SV,
like the density and stochastic behavior of transmembrane ion
channels (Lemay et al., 2011; Pueyo et al., 2011; Szentandrassy et al.,
2015), intensity of cell-to-cell coupling (Zaniboni et al., 2000;Please cite this article as: Nanasi, P.P et al., Implication of frequency-dep
Progress in Biophysics and Molecular Biology, https://doi.org/10.1016/j.pbMagyar et al., 2015), action potential duration and morphology
(Heijman et al., 2013), stimulation frequency (Johnson et al., 2010)
and intracellular calcium handling (Johnson et al., 2013; Kistamas
et al., 2015).
The major concernwith simple determination of the magnitude
of SV, which can easily be calculated and visualized using the
Poincare plot (Van der Linde et al., 2005; Johnson et al., 2010), is
that almost all the interventions used to modulate SV are known to
change APD as well. This is problematic because SV is a sharp
function of APD itself as demonstrated in Fig. 5.A,B. The specific
actions of drugs or interventions on SV can be studied exclusively
when SV data are cleared from the consequences of the concomi-
tant APD changes. This is achieved by introducing the term of
relative variability (RV), when the drug induced change in SV is
evaluated in light of the APD change (Szentandrassy et al., 2015;
Magyar et al., 2016). Accordingly, data points appear above the solid
curve of the conventional SV-APD relationship indicate elevated RV
values, while those located under the curve correspond to reduction
of RV (Fig. 5.A,B). This concept of RV allows identification of the
individual cardiac ion currents influencing RV (Fig. 5.D,E). Accord-
ingly, suppression of IKr, IKs, ICa increased RV (similar effects were
observed with inhibition of ICl and INCX) suggesting that these
currents keep RV at a low level under physiological conditions
(Szentandrassy et al., 2015). Indeed, inhibition of IKr and IKs were
shown to increase beat-to-beat variability, while it was decreased
by augmentation of IKs (Lengyel et al., 2007; Johnson et al., 2010). In
contrast, after blocking of INa RV was reduced indicating that INa
increases RV physiologically (Szentandrassy et al., 2015). Since ICa,
IKr and IKs are the major ion currents responsible for the negative
feedback regulation of APD, their normal activity is essential for
keeping RV at a reasonably low level. Similarly, Ca2þ-dependent Cl
current can stabilize APDwhen the intracellular Ca2þ level ([Ca2þ]i)
is elevated (Horvath et al., 2016; Hegyi et al., 2017). The other
important factor known to modify RV is [Ca2þ]i and the amplitude
of the [Ca2þ]i transient (Kistamas et al., 2015a). This is shown in
Fig. 5.F, where elevation of [Ca2þ]i using a Ca2þ-ionophore com-
pound increased, while its reduction by the Ca2þchelator BAPTA
reduced RV. Similar effects were observed after blocking the ac-
tivity of sarcoplasmic reticulum (SR) with ryanodine or CPA. It is
likely, therefore, that the elevation of SV observed at high rate
dependent frequencies are related to the concomitant [Ca2þ]i
accumulation (Fig. 5.C, Kistamas et al., 2015a). Further factors, like
an oxidative milieu, high temperature, or application of single cells
instead of multicellular preparations were also shown to increase
RV (Kistamas et al., 2015b), while the ß-adrenergic receptor agonist
isoproterenol resulted a reduction of RV - probably due to the
intensification of ICa, IKs and IKr.
5. Frequency-dependent properties of cardiac arrhythmias
One classification of arrhythmias is based on the experience that
both tachycardia and bradycardia are proarrhythmic conditions.
Elevation of heart rate (often as a consequence of the increased
sympathetic activity) results is Ca2þ overload of the cells. For a
limited period of time this extra calcium can be sequestrated in the
SR and mitochondria. Sustained mitochondrial Ca2þ influx may
interferewith ATP production resulting in insufficient Naþ removal,
which is converted to further accumulation of Ca2þ via the Naþ/
Ca2þ exchanger (Bers, 2000). Within a certain number of cardiac
cycles SR alsowill be overloadedwith Ca2þ initiating a spontaneous
Ca2þ release, since this is the only way for the overloaded SR (as
well as for the cardiac myocyte) to get rid of the extra Ca2þ using
the Naþ/Ca2þ exchanger. The inward current generated by Naþ/
Ca2þ exchanger causes transient depolarization of the cell mem-
brane, typically following terminal repolarization, called thereforeendent protocols in antiarrhythmic and proarrhythmic drug testing,
iomolbio.2019.11.001
Fig. 5. A,B: The SV-APD relationship obtained by lengthening and shortening APD with inward and outward current pulses, respectively. C: SV-APD relationship obtained by
changing the pacing cycle length. D,E: Effects of various ion channel modifier agents and isoproterenol on RV. F: Changes of RV in response to manipulation of [Ca2þ]i and [Ca2þ]i
transients. Solid curves represent the function obtained with the electrical pulses. Points above the curve indicate elevated, while ones under the curve correspond to reduced RV
values.
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DADs may stimulate the neighbouring myocytes resulting in ex-
trasystoles (trigger). In addition to these changes, elevated [Ca2þ]i
leads to reduction of conduction velocity (substrate) due to the
closure of gap junctions, increasing thus the probability of re-entry
arrhythmias.
When the heart rate is low, the relative contribution of the re-
fractory period to the whole cardiac cycle is diminished, also
favouring to development of re-entry. More importantly, APD is
concomitantly lengthened at low heart rates. This prolongation of
APD allows the reactivation of inward currents, like ICa, which may
cause a second transient depolarization before terminal repolari-
zation (Fozzard, 1992). Early afterdepolarizations (EADs) may act as
a trigger to initiate extrasystoles. The incidence of EADs is elevated
in case of an imbalance between inward and outward currents
causing an inward shift of net membrane current during the
plateau. As shown in Fig. 1.C and 1.F, this is the case also when APD
increases, i.e. when the net outward current is reduced. Under
these conditions the substrate is the increased electrical instability
during the plateau phase, reflected also by the increased beat-to-
beat variability of APD, resulting larger temporal inhomogeneity.
6. Concluding remarks
The most important implication of the normal and reverse rate-
dependent nature of cardioactive drug action is that awide range of
stimulation frequency has to be tested when an agent acting on a
cardiac ion channel is characterized electrophysiologically. A
further problem arises from the large differences between the
normal heart rate in humans and the rapid spontaneous frequency
of the smaller laboratory animals, like rats, mice, guinea pigs andPlease cite this article as: Nanasi, P.P et al., Implication of frequency-dep
Progress in Biophysics and Molecular Biology, https://doi.org/10.1016/j.pbrabbits, typically used for drug studies. Therefore, larger mammals,
like dogs or cats, may likely provide more relevant data. Thirdly, we
have to realize that the normal heart rate of an animal, including
humans, has been largely optimized by the evolution. Changes in
heart rate to either direction may increase arrhythmia propensity.
This may help to understand the reasons of the disappointing
outcomes of the CAST and SWORD studies, and more importantly,
may help to prevent similar pitfalls in the future.
Although all details of the frequency-dependent aspects of
antiarrhythmic and proarrhythmic mechanisms is not fully
explored at present, it is clear that all they show rate-dependent
properties. By application of frequency-dependent experimental
protocols less rate-dependent complications with the new antiar-
rhythmic agents are anticipated.
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